Cardlytics (NASDAQ:CDLX) CEO Amit Gupta Sells 69,833 Shares of Stock

Cardlytics, Inc. (NASDAQ:CDLX) CEO Amit Gupta sold 69,833 shares of the company’s stock in a transaction dated Monday, April 6th. The shares were sold at an average price of $1.19, for a total transaction of $83,101.27. Following the completion of the transaction, the chief executive officer directly owned 987,387 shares in the company, valued at $1,174,990.53. The trade was a 6.61% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Amit Gupta also recently made the following trade(s):

• On Thursday, April 2nd, Amit Gupta sold 54,225 shares of Cardlytics stock. The stock was sold at an average price of $1.04, for a total transaction of $56,394.00.
• On Wednesday, April 1st, Amit Gupta sold 62,549 shares of Cardlytics stock. The shares were sold at an average price of $0.99, for a total transaction of $61,923.51.
• On Wednesday, February 18th, Amit Gupta sold 45,159 shares of Cardlytics stock. The shares were sold at an average price of $0.93, for a total transaction of $41,997.87.
• On Tuesday, February 17th, Amit Gupta sold 52,049 shares of Cardlytics stock. The shares were sold at an average price of $0.90, for a total transaction of $46,844.10.

Cardlytics Price Performance

Shares of CDLX opened at $1.18 on Tuesday. Cardlytics, Inc. has a 1-year low of $0.66 and a 1-year high of $3.28. The stock has a market cap of $64.98 million, a PE ratio of -0.61 and a beta of 0.91. The firm has a 50-day simple moving average of $0.90 and a two-hundred day simple moving average of $1.32.

Cardlytics (NASDAQ:CDLX) last announced its quarterly earnings results on Wednesday, March 4th. The company reported ($0.15) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.07) by ($0.08). Cardlytics had a negative net margin of 44.36% and a negative return on equity of 370.98%. The company had revenue of $56.10 million for the quarter, compared to analyst estimates of $54.46 million. As a group, sell-side analysts expect that Cardlytics, Inc. will post -1.52 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on CDLX shares. Bank of America restated an “underperform” rating on shares of Cardlytics in a research report on Thursday, March 5th. Evercore set a $1.00 price target on shares of Cardlytics in a research report on Friday, March 6th. Weiss Ratings reissued a “sell (d-)” rating on shares of Cardlytics in a research report on Monday, December 29th. Finally, Wall Street Zen raised shares of Cardlytics from a “sell” rating to a “hold” rating in a research report on Saturday. Two analysts have rated the stock with a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, Cardlytics presently has an average rating of “Reduce” and a consensus price target of $1.75.

Institutional Trading of Cardlytics

Hedge funds have recently modified their holdings of the stock. Citizens Financial Group Inc. RI acquired a new stake in shares of Cardlytics in the third quarter valued at $1,260,000. Quinn Opportunity Partners LLC raised its holdings in Cardlytics by 900.0% in the third quarter. Quinn Opportunity Partners LLC now owns 1,100,000 shares of the company’s stock valued at $2,673,000 after acquiring an additional 990,000 shares in the last quarter. Global Retirement Partners LLC raised its holdings in Cardlytics by 67.3% in the third quarter. Global Retirement Partners LLC now owns 34,800 shares of the company’s stock valued at $85,000 after acquiring an additional 14,000 shares in the last quarter. Sand Hill Global Advisors LLC acquired a new stake in Cardlytics in the second quarter valued at approximately $35,000. Finally, XTX Topco Ltd raised its holdings in Cardlytics by 143.5% in the second quarter. XTX Topco Ltd now owns 85,971 shares of the company’s stock valued at $141,000 after acquiring an additional 50,663 shares in the last quarter. 68.10% of the stock is currently owned by institutional investors and hedge funds.

About Cardlytics

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.